| |
Webinar
Hot Melt Extrusion for Poorly Soluble Drugs
|
October 6th, 2009
|
10:00 am - 11:00 am, Eastern Standard Time (New York)
|
|
|
3:00 pm - 4:00 pm, GMT (London)
|
Hot Melt Extrusion (HME) is becoming an important technology within the Pharmaceutical
Industry as a means for formulating poorly water-soluble active pharmaceutical ingredients (API’s).
Additionally, HME provides greater drug bioavailability.
This Webinar will cover:
- A review of Hot Melt Extrusion Technology.
- Modification to the traditional extrusion system for pharmaceutical needs.
- An economically-feasible continuous process and solvent-free manufacture.
- The role of polymers and plasticizers.
- The use of low temperatures to minimize API degradation.
- Optimization of HME Formulation and Process.
Webinar speakers include:
Dr. Karl Kolter, Ph.D.
Head of Global R&D Project Management
Excipients
BASF SE, Germany, Pharma Ingredients
and Services
Scott T. Martin
Senior Application Specialist
Thermo Fisher Scientific
|
|
 |
News |
| |
|
June 18, 2010:
BASF one of the top three best raw materials suppliers of the Sindusfarma’s Quality 2010 Prize
(english) June 18, 2010:
Investigating the Up Scaling Properties of a Sustained Release Coating Using Side Vented Pan Coating Technology
(english) April 8, 2010:
BASF showcases expertise across pharmaceutical value chain at CPhI Japan 2010
(english) March 2, 2010:
BASF showcases its expertise at the 7th World Meeting on Pharmaceutics, Biopharmaceutic and Pharmaceutical Technology in Malta
(english) February 10, 2010:
BASF has joined forces with GEA Niro in cGMP spray drying for
custom synthesis pharma production
(english, deutsch)
|
|
 |
Product Search |
 |
|
|
